Development of the ESEx index: a tool for predicting risk of recurrent severe COPD exacerbations

被引:0
|
作者
Valera-Novella, Elisa [4 ,5 ]
Bernabeu-Mora, Roberto [1 ,2 ,3 ]
Montilla-Herrador, Joaquina [4 ,5 ]
Escolar-Reina, Pilar [4 ,5 ]
Garcia-Vidal, Jose Antonio [5 ,6 ]
Medina-Mirapeix, Francesc [4 ,5 ]
机构
[1] Hosp Gen Univ Morales Meseguer, Dept Pneumol, Adva Marques Velez S-N, Murcia 30008, Spain
[2] Univ Murcia, Dept Internal Med, Murcia, Spain
[3] Inst Murciano Invest Biosanitaria IMIB, Res Grp Fisioterapia & Discapacidad, Murcia, Spain
[4] Univ Murcia, Dept Phys Therapy, Murcia, Spain
[5] Inst Murciano Invest Biosanitaria Virgen Arrixaca, Res Grp Fisioterapia & Discapacidad, Murcia, Spain
[6] Univ Murcia, Murcia, Spain
关键词
COPD; five-repetition sit-to-stand test (5-STS); hospital admission; recurrent exacerbation; 6-minute-walk test (6MWT); OBSTRUCTIVE PULMONARY-DISEASE; HOSPITALIZATION;
D O I
10.1177/20406223231155115
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background:In chronic obstructive pulmonary disease (COPD), multiple recurrent severe exacerbations that require hospitalization can occur. These events are strongly associated with death and other clinical complications. Objectives:We aimed to develop a prognostic model that could identify patients with COPD that are at risk of multiple recurrent severe exacerbations within 3 years. Design:Prospective cohort. Methods:The derivation cohort comprised patients with stable, moderate-to-severe COPD. Multivariable logistic regression analyses were performed to develop the final model. Based on regression coefficients, a simplified index (ESEx) was established. Both, model and index, were assessed for predictive performance by measuring discrimination and calibration. Results:Over 3 years, 16.4% of patients with COPD experienced at least three severe recurrent exacerbations. The prognostic model showed good discrimination of high-risk patients, based on three characteristics: the number of severe exacerbations in the previous year, performance in the five-repetition sit-to-stand test, and in the 6-minute-walk test. The ESEx index provided good level of discrimination [areas under the receiver operating characteristic curve (AUCs): 0.913]. Conclusions:The ESEx index showed good internal validation for the identification of patients at risk of three recurrent severe COPD exacerbations within 3 years. These tools could be used to identify patients who require early interventions and motivate patients to improve physical performance to prevent recurrent exacerbations.
引用
收藏
页数:11
相关论文
共 34 条
  • [1] Prediction of risk of COPD exacerbations by the BODE index
    Marin, Jose M.
    Carrizo, Santiago J.
    Casanova, Ciro
    Martinez-Camblor, Pablo
    Soriano, Joan B.
    Agusti, Alvar G. N.
    Celli, Bartolome R.
    RESPIRATORY MEDICINE, 2009, 103 (03) : 373 - 378
  • [2] A Nomogram for Predicting Severe Exacerbations in Stable COPD Patients
    Chen, Xueying
    Wang, Qi
    Hu, Yinan
    Zhang, Lei
    Xjong, Weining
    Xu, Yongjian
    Yu, Jun
    Wang, Yi
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 379 - 388
  • [3] Dynamic hyperinflation is a risk factor for mortality and severe exacerbations in COPD patients
    Lorenzana, Isabel
    Galera, Raul
    Casitas, Raquel
    Martinez-Ceron, Elisabet
    Castillo, Maria Alejandra
    Alfaro, Enrique
    Cubillos-Zapata, Carolina
    Garcia-Rio, Francisco
    RESPIRATORY MEDICINE, 2024, 225
  • [4] A risk stratification tool for exacerbations of COPD: time to switch to DECAF
    Costello, Richard W.
    Cushen, Breda
    THORAX, 2016, 71 (06) : 489 - 490
  • [5] Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD
    Huang, Yueh Lan
    Lai, Chih-Cheng
    Wang, Ya-Hui
    Wang, Cheng-Yi
    Wang, Jen-Yu
    Wang, Hao-Chien
    Yu, Chong-Jen
    Chen, Likwang
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 2987 - 2996
  • [6] Exploring the impact of number and type of comorbidities on the risk of severe COPD exacerbations in Korean Population: a Nationwide Cohort Study
    Kim, Youngmee
    Kim, Ye-Jee
    Kang, Yu Mi
    Cho, Won-Kyung
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [7] Development and validation of a predictive model to identify patients at risk of severe COPD exacerbations using administrative claims data
    Annavarapu, Srinivas
    Goldfarb, Seth
    Gelb, Melissa
    Moretz, Chad
    Renda, Andrew
    Kaila, Shuchita
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 2121 - 2130
  • [8] InforMing the PAthway of COPD Treatment (IMPACT) trial: fibrinogen levels predict risk of moderate or severe exacerbations
    Singh, Dave
    Criner, Gerard J.
    Dransfield, Mark T.
    Halpin, David M. G.
    Han, MeiLan K.
    Lange, Peter
    Lettis, Sally
    Lipson, David A.
    Mannino, David
    Martin, Neil
    Martinez, Fernando J.
    Miller, Bruce E.
    Wise, Robert
    Zhu, Chang-Qing
    Lomas, David
    RESPIRATORY RESEARCH, 2021, 22 (01)
  • [9] Development of a Communication Tool between Patients and Physicians for Recognizing COPD Exacerbations in Japan
    Jones, Paul
    Hataji, Osamu
    Suzukamo, Yoshimi
    Crawford, Bruce
    Sakai, Yoko
    Ishii, Takeo
    Sato, Keiko
    Sasaki, Eri
    Hashimoto, Kenichi
    Oga, Toru
    COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2023, 20 (01) : 216 - 223
  • [10] Screening eosinophil counts and risk of exacerbations after inhaled corticosteroid withdrawal in severe COPD
    Calverley, Peter M. A.
    Wouters, Emiel F. M.
    Finnigan, Helen
    Tetzlaff, Kay
    Magnussen, Helgo
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48